Publicaciones (257) Publicaciones en las que ha participado algún/a investigador/a

2023

  1. A Functional Pipeline of Genome-Wide Association Data Leads to Midostaurin as a Repurposed Drug for Alzheimer’s Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 15

  2. Acute intrahippocampal administration of melanin-concentrating hormone impairs memory consolidation and decreases the expression of MCHR-1 and TrkB receptors

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 123

  3. Administration of Linoleoylethanolamide Reduced Weight Gain, Dyslipidemia, and Inflammation Associated with High-Fat-Diet-Induced Obesity

    Nutrients, Vol. 15, Núm. 20

  4. Antidepressant Medication Does Not Contribute to the Elevated Circulating Concentrations of Acylethanolamides Found in Substance Use Disorder Patients

    International Journal of Molecular Sciences, Vol. 24, Núm. 19

  5. Antipsychotic Medication Influences the Discriminative Value of Acylethanolamides as Biomarkers of Substance Use Disorder

    International journal of molecular sciences, Vol. 24, Núm. 11

  6. Associations of hypomagnesemia in patients seeking a first treatment of alcohol use disorder

    Drug and Alcohol Dependence, Vol. 245

  7. Awake and Sleep Bruxism Prevalence and Their Associated Psychological Factors in First-Year University Students: A Pre-Mid-Post COVID-19 Pandemic Comparison

    International Journal of Environmental Research and Public Health, Vol. 20, Núm. 3, pp. 2452

  8. Consecuencias de la obesidad en la mujer: La importancia de la adherencia y participación en programas de salud. SAMEM 23; 23º Encuentro Nacional de Salud y Medicina de la Mujer

    Toko-ginecología práctica, pp. 31-36

  9. Exploración mamaria: Técnica y cuidados

    Manual práctica de la enseñanza de salud sexual y reproductiva (Elsevier), pp. 29-58

  10. Oleoylethanolamide attenuates cocaine-primed reinstatement and alters dopaminergic gene expression in the striatum

    Behavioral and Brain Functions, Vol. 19, Núm. 1

  11. PREVALENCE OF ELECTROCARDIOGRAPHIC ALTERATIONS IN ATHLETES ASSOCIATED WITH CARDIOVASCULAR RISK PARAMETERS

    Revista Internacional de Medicina y Ciencias de la Actividad Fisica y del Deporte, Vol. 23, Núm. 93, pp. 227-240

  12. Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

  13. Plasma Lysophosphatidic Acid Concentrations in Sex Differences and Psychiatric Comorbidity in Patients with Cocaine Use Disorder

    International Journal of Molecular Sciences, Vol. 24, Núm. 21

  14. Plasma concentrations of lysophosphatidic acid and the expression of its receptors in peripheral blood mononuclear cells are altered in patients with cocaine use disorders

    Translational Psychiatry, Vol. 13, Núm. 1

  15. Reelin Plasma Levels Identify Cognitive Decline in Alcohol Use Disorder Patients During Early Abstinence: The Influence of APOE4 Expression

    The international journal of neuropsychopharmacology, Vol. 26, Núm. 8, pp. 545-556